International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 7, Issue 4 (July-August 2025) Submit your research before last 3 days of August to publish your research paper in the issue of July-August.

Bortezomib - Induced Paralytic Ileus: Uncommon but Crucial

Author(s) Mr. Rimal John Roy, Dr. Sara Kurien Kodiattu, Ms. Rency Abraham, Dr. Jacob Jesurun R S
Country India
Abstract Bortezomib is a targeted anti - cancer medication used primarily to treat Multiple Myeloma and Mantle Cell Lymphoma in adults. It is classified as a Protease Inhibitor, which works by reversibly inhibiting the protein complex responsible for degrading damaged proteins within cells.[1] We report the case of a patient with Multiple Myeloma who developed Paralytic Ileus while on Bortezomib.
Keywords Multiple Myeloma, Protease Inhibitor, Paralytic Ileus, VRd, KPD
Field Medical / Pharmacy
Published In Volume 7, Issue 4, July-August 2025
Published On 2025-08-10
DOI https://doi.org/10.36948/ijfmr.2025.v07i04.53056
Short DOI https://doi.org/g9w5hv

Share this